• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 18
  • 9
  • 7
  • 7
  • 6
  • 5
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 62
  • 9
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Rôle de GINIP, une nouvelle protéine régulatrice des protéines G inhibitrices, dans la modulation de la douleur neuropathique / Role of GINIP, a new regulatory G inhibitory protein, in the modulation of neuropathic pain

Lo re, Laure 27 November 2014 (has links)
Le système somato-sensoriel permet à l'organisme de percevoir une large palette de stimuli externes/internes, qui peuvent être soit agréables, soit nocifs. Le corps cellulaire des neurones somato-sensoriels, responsables de ces processus et qui innervent tous les organes du corps, est situé dans les ganglions de la racine dorsale. La douleur est perçue par les nocicepteurs qui constituent un ensemble hétérogène de neurones, aussi bien d'un point de vue fonctionnel, électrophysiologique que moléculaire. Afin de mieux comprendre la spécialisation fonctionnelle des nocicepteurs, une des stratégies de l'équipe a été d'identifier de nouveaux marqueurs moléculaires exprimés par des sous-populations des neurones du DRG et de mettre en place des outils génétiques pour étudier leur fonction spécifique. Nous avons mis en évidence un nouveau gène, qui définit une sous-population de nocicepteurs. Suite à mes travaux de thèse, qui ont révélés la fonction moléculaire de la protéine associée à ce gène, nous l'avons nommé GINIP pour Galpha INhibitory Interacting Protein. Au cours de ma thèse, j'ai montré que : - GINIP interagit physiquement avec les protéines G-alpha inhibitrices- la perte de fonction de GINIP (souris GINIP KO) amplifie les douleurs de type neuropathique- le mécanisme sous-jacent fait intervenir la signalisation GABAergique Les douleurs pathologiques sont, entre autres, dues à un disfonctionnement des nocicepteurs, et leurs mécanismes restent mal connus. Dans ce contexte, l'ensemble de mes résultats met en évidence une nouvelle voie impliquée dans la régulation négative des nocicepteurs, qui pourra à l'avenir être la cible de stratégies thérapeutiques. / The somato-sensory system allows our organism to detect a myriad of external and internal stimuli that can range from innocuous stimuli (pleasant touch,etc) to noxious ones (burns, tissue injury, etc). The somato-sensory neurons involved in these processes innervate the entire organism and have their cell bodies clustered within the dorsal root ganglion. Pain is a modality of the somatosensory system, sensed through nociceptors. Nociceptors represent a heterogeneous class of somato-sensory neurons with respect to functional, electrophysiological and molecular criteria. In order to expand the knowledge of the functional specialization of nociceptors, our team's strategy aimed at identifying new molecular markers of nociceptors subsets. Subsequent design of the corresponding genetic tools allowed us investigating their specific function. Therefore, we found a gene that was never described before and that marks a specific subset of nociceptors. We named it GINIP (Gaplha Inhibitory Interacting Protein) as during my thesis I showed that:- GINIP physically interacts with inhibitory G-proteins- GINIP loss of function (GINIP knock out mouse) leads to the amplification of neuropathic pain- the associated mechanism involves GABAergic signalingPathological pain (chronic inflammatory pain and neuropathic pain) is, among others, a consequence of nociceptor dysfunction. Importantly, the mechanisms leading to this aberrant function are still not totally understood. Altogether, my results underscore a new pathway involved in the negative control of nociceptors under neuropathic pain conditions, and this opens a path for new therapeutic strategies.
12

Morbidade no Hospital das Clínicas : identificação de perfis e desenvolvimento de instrumento de monitoramento / Morbidity at the Hospital das Clínicas: profile identification and development of monitoring instruments

Zanetta, Sergio Fernando Rodrigues 05 August 2003 (has links)
O presente trabalho analisa as saídas do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo e descreve o perfil da demanda através da aplicação do sistema de classificação de internações hospitalares \"Diagnosis Related Groups - DRGs\". Verifica o uso de DRGs como instrumento de mensuração do produto hospitalar no que tange ao volume de produção, nível de utilização de recursos, casemix do hospital e complexidade assistencial. Resultados desse trabalho apontam o sistema DRG como de fácil utilização com dados rotineiramente coletados pelos serviços de informação dos hospitais e que pode ser utilizado como instrumento para qualificação da gestão de unidades hospitalares e do sistema de saúde / This study analyzes the discharges from the Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, and describes the demand profile through the application of the classification system for hospital admissions \"Diagnosis Related Groups - DRGs\" as measuring instrument of the hospital service concerning production volume, resource utilization level, hospital casemix and complexity of the assistance provided. The results of the study show the easy application of the DRG system, using data routinely collected by hospitals information systems, and its usefulness to be used as an instrument to qualify hospital management as well as the health system as a whole
13

Mobilização neural: avaliação molecular e comportamental em ratos Wistar após indução de dor neuropática. / Neural mobilization: molecular and behavioral assessment in rats after induction of neuropathic pain.

Santos, Fabio Martinez dos 28 July 2015 (has links)
A técnica de Mobilização Neural (MOB) é um método não invasivo que demonstrou tanto na pesquisa básica, como na pesquisa clinica ser eficaz na redução da sensibilidade à dor. O presente, estudo visa examinar os efeitos da MOB na disfunção locomotora, na força muscular, nas alterações morfológicas no nervo isquiático e nas alterações moleculares induzida pela constrição crônica (CCI) do nervo isquiático de ratos Wistar. Para analisar a disfunção locomotora utilizamos o índice funcional do nervo Isquiático (IFC). Para analisar a força muscular, o sistema Biopac System. A ultraestrutura do nervo foi analisada pela técnica de microscopia eletrônica de transmissão e as alterações moleculares por meio de ensaios de Western blot. Ao finalizarmos os tratamentos com MOB os animais foram eutanasiados e os tecidos como, nervo isquiático, gânglios das raizes posteriores (DRG L4-L6) e Susbtância Cinzenta Periaquedutal (PAG) foram retirados. Os DRG´s foram processados pela técnica de Western Blot para a detecção da substância P (SP), receptor de potencial transitório vanilóide tipo I (TRPV1) e receptores opióides dos tipos µ (MOR), δ (DOR) e k (KOR). Com relação a PAG, analisamos somente os receptores opióides por Western Blot. Nossos resultados demonstraram uma reverção da disfunção locomotora induzida pela CCI após a MOB e aumentou 172% a força do músculo tibial anterior nos animais tratados quando comparado com os animais do grupo CCI. Nossos estudos sobre a ultraestrutura do nervo isquiático demonstraram intenso processo de degeneração Waleriana após a CCI e regeneração após a MOB. Podemos sugerir um papel importante da MOB na modulação da expressão da SP e do TRPV 1. Sobre os receptores DOR e KOR no DRG, não encontramos alterações estatísticas entre os grupos, mas observamos um aumento da expressão de MOR após a MOB. Na PAG, nós observamos uma diminuição de DOR e KOR no grupo CCI e aumento após a MOB. Por outro lado, não encontramos alterações estatíticas para o receptor MOR. Baseado nestes achados, podemos sugerir que a MOB reverte a disfunção locomotora, aumenta a força muscular, induz a regeneração do nervo isquiático, modula a SP e TRPV 1 e aumentou a expressão de MOR no DRG´s. Sugerimos ainda que, a analsegia induzida pela técnica de MOB possa ter um envolvimento também com o sistema inibitório descendente de dor resultando na inibição da transmissão do estímulo nociceptivo aferente e assim, diminuindo a dor neuropática devido influência da MOB sobre os opióides na PAG. / Neural mobilization technique (MOB) is a noninvasive method that demonstrated to be effective in reducing pain sensitivity in both clinical and research study. The present study aims to examine the effects of MOB in locomotors dysfunction, muscle strength, morphological changes in sciatic nerve and molecular changes induced by chronic constriction (CCI) of the sciatic nerve in Wistar rats. To analyze locomotors dysfunction we used the Sciatic nerve functional index (SFI). To analyze muscle strength, was used Biopac System. The nerve morphology was analyzed using electron microscopy and molecular changes through western blot assays. After MOB treatments, animals were euthanized and tissues such as, sciatic nerve, the posterior root ganglions (DRG L4-L6) and substance periaqueductal gray (PAG) were removed. The DRG were processed by western blot for detection of substance P (SP), transient receptor potential vanilloid type I (TRPV1) and opioids receptors (MOR, DOR, KOR). Regarding PAG, we analyze only opioids receptors. Our results demonstrated a full reversal of locomotors dysfunction-induced by CCI after MOB treatment and an increase of 172% on maximal tetanic muscle strength in animals treated with MOB when compared to the CCI group. Our studies on photomicrography of sciatic nerve showed an intense Wallerian degeneration process in CCI animals and an intense regeneration of myelinated fibers. In western blot assays, we identified, in DRG, an increase of SP and TRPV1 expression after CCI and a decrease of optical density after MOB treatment. Regarding opioid receptor, we did not identify statistical changes on DOR and KOR in DRG, but we observed an increased expression of MOR in CCI after MOB treatment group. In PAG analyses, we observed a decrease in DOR and KOR expression after MOB treatment when compare with CCI animals. On the other hand, we did not identify any changes on MOR receptor. Based on our findings, we suggest that treatment with neural mobilization technique it is able to reverses the locomotors dysfunction and increases maximum tetanic force of the tibialis anterior muscle after CCI. Furthermore, the same treatment was also able to induce a severe regeneration in the sciatic nerve after treatment. Still, we can suggest an important role of MOB in modulating SP and TRPV 1 expression. We suggest that antinociceptive effect induced by MOB technique can also be involved with descending pain inhibitory system resulting in inhibition of the transmission of afferent nociceptive stimulus and thereby reducing neuropathic pain because of the influence of MOB opioids in the PAG.
14

Mobilização neural: avaliação molecular e comportamental em ratos Wistar após indução de dor neuropática. / Neural mobilization: molecular and behavioral assessment in rats after induction of neuropathic pain.

Fabio Martinez dos Santos 28 July 2015 (has links)
A técnica de Mobilização Neural (MOB) é um método não invasivo que demonstrou tanto na pesquisa básica, como na pesquisa clinica ser eficaz na redução da sensibilidade à dor. O presente, estudo visa examinar os efeitos da MOB na disfunção locomotora, na força muscular, nas alterações morfológicas no nervo isquiático e nas alterações moleculares induzida pela constrição crônica (CCI) do nervo isquiático de ratos Wistar. Para analisar a disfunção locomotora utilizamos o índice funcional do nervo Isquiático (IFC). Para analisar a força muscular, o sistema Biopac System. A ultraestrutura do nervo foi analisada pela técnica de microscopia eletrônica de transmissão e as alterações moleculares por meio de ensaios de Western blot. Ao finalizarmos os tratamentos com MOB os animais foram eutanasiados e os tecidos como, nervo isquiático, gânglios das raizes posteriores (DRG L4-L6) e Susbtância Cinzenta Periaquedutal (PAG) foram retirados. Os DRG´s foram processados pela técnica de Western Blot para a detecção da substância P (SP), receptor de potencial transitório vanilóide tipo I (TRPV1) e receptores opióides dos tipos µ (MOR), δ (DOR) e k (KOR). Com relação a PAG, analisamos somente os receptores opióides por Western Blot. Nossos resultados demonstraram uma reverção da disfunção locomotora induzida pela CCI após a MOB e aumentou 172% a força do músculo tibial anterior nos animais tratados quando comparado com os animais do grupo CCI. Nossos estudos sobre a ultraestrutura do nervo isquiático demonstraram intenso processo de degeneração Waleriana após a CCI e regeneração após a MOB. Podemos sugerir um papel importante da MOB na modulação da expressão da SP e do TRPV 1. Sobre os receptores DOR e KOR no DRG, não encontramos alterações estatísticas entre os grupos, mas observamos um aumento da expressão de MOR após a MOB. Na PAG, nós observamos uma diminuição de DOR e KOR no grupo CCI e aumento após a MOB. Por outro lado, não encontramos alterações estatíticas para o receptor MOR. Baseado nestes achados, podemos sugerir que a MOB reverte a disfunção locomotora, aumenta a força muscular, induz a regeneração do nervo isquiático, modula a SP e TRPV 1 e aumentou a expressão de MOR no DRG´s. Sugerimos ainda que, a analsegia induzida pela técnica de MOB possa ter um envolvimento também com o sistema inibitório descendente de dor resultando na inibição da transmissão do estímulo nociceptivo aferente e assim, diminuindo a dor neuropática devido influência da MOB sobre os opióides na PAG. / Neural mobilization technique (MOB) is a noninvasive method that demonstrated to be effective in reducing pain sensitivity in both clinical and research study. The present study aims to examine the effects of MOB in locomotors dysfunction, muscle strength, morphological changes in sciatic nerve and molecular changes induced by chronic constriction (CCI) of the sciatic nerve in Wistar rats. To analyze locomotors dysfunction we used the Sciatic nerve functional index (SFI). To analyze muscle strength, was used Biopac System. The nerve morphology was analyzed using electron microscopy and molecular changes through western blot assays. After MOB treatments, animals were euthanized and tissues such as, sciatic nerve, the posterior root ganglions (DRG L4-L6) and substance periaqueductal gray (PAG) were removed. The DRG were processed by western blot for detection of substance P (SP), transient receptor potential vanilloid type I (TRPV1) and opioids receptors (MOR, DOR, KOR). Regarding PAG, we analyze only opioids receptors. Our results demonstrated a full reversal of locomotors dysfunction-induced by CCI after MOB treatment and an increase of 172% on maximal tetanic muscle strength in animals treated with MOB when compared to the CCI group. Our studies on photomicrography of sciatic nerve showed an intense Wallerian degeneration process in CCI animals and an intense regeneration of myelinated fibers. In western blot assays, we identified, in DRG, an increase of SP and TRPV1 expression after CCI and a decrease of optical density after MOB treatment. Regarding opioid receptor, we did not identify statistical changes on DOR and KOR in DRG, but we observed an increased expression of MOR in CCI after MOB treatment group. In PAG analyses, we observed a decrease in DOR and KOR expression after MOB treatment when compare with CCI animals. On the other hand, we did not identify any changes on MOR receptor. Based on our findings, we suggest that treatment with neural mobilization technique it is able to reverses the locomotors dysfunction and increases maximum tetanic force of the tibialis anterior muscle after CCI. Furthermore, the same treatment was also able to induce a severe regeneration in the sciatic nerve after treatment. Still, we can suggest an important role of MOB in modulating SP and TRPV 1 expression. We suggest that antinociceptive effect induced by MOB technique can also be involved with descending pain inhibitory system resulting in inhibition of the transmission of afferent nociceptive stimulus and thereby reducing neuropathic pain because of the influence of MOB opioids in the PAG.
15

Morbidade no Hospital das Clínicas : identificação de perfis e desenvolvimento de instrumento de monitoramento / Morbidity at the Hospital das Clínicas: profile identification and development of monitoring instruments

Sergio Fernando Rodrigues Zanetta 05 August 2003 (has links)
O presente trabalho analisa as saídas do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo e descreve o perfil da demanda através da aplicação do sistema de classificação de internações hospitalares \"Diagnosis Related Groups - DRGs\". Verifica o uso de DRGs como instrumento de mensuração do produto hospitalar no que tange ao volume de produção, nível de utilização de recursos, casemix do hospital e complexidade assistencial. Resultados desse trabalho apontam o sistema DRG como de fácil utilização com dados rotineiramente coletados pelos serviços de informação dos hospitais e que pode ser utilizado como instrumento para qualificação da gestão de unidades hospitalares e do sistema de saúde / This study analyzes the discharges from the Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, and describes the demand profile through the application of the classification system for hospital admissions \"Diagnosis Related Groups - DRGs\" as measuring instrument of the hospital service concerning production volume, resource utilization level, hospital casemix and complexity of the assistance provided. The results of the study show the easy application of the DRG system, using data routinely collected by hospitals information systems, and its usefulness to be used as an instrument to qualify hospital management as well as the health system as a whole
16

Longitudinal extension of primary afferents is regulated by spingosine 1-phosphate receptors and tyrosine kinase receptor B in the embryonic spinal cord via a brain derived neurotrophic factor related mechanism

McNamara, Michelle 01 January 2015 (has links)
Primary sensory afferent outgrowth within the developing longitudinal pathway of the spinal cord is important for intrasegmental and intersegmental communication that underlies coordination and development of reflexes and contributes to sensory perception. The endogenous mechanisms that regulate primary sensory afferent extension are the primary focus of this dissertation. This dissertation tested the hypothesis that primary sensory afferent extension in the longitudinal pathway is regulated by sphingosine 1-phosphate type 1 receptor (S1P1R) and tyrosine kinase receptor B (TrkB) through a brain derived neurotrophic factor (BDNF) related mechanism. To test this hypothesis we used embryonic day five (E5) chicken embryos, as this is the developmental time point when sensory afferents are growing along the longitudinal axis of the spinal cord but have not yet turned ventrally to make connections with the grey matter of the spinal cord. Chicken embryos were removed from their in ovo environment to allow for labeling of primary afferent neurons in the thoracic 3/4 (T3/4) dorsal root ganglia (DRG). Tissue was then put into culture with or without various pharmacological agents and subsequently assayed for length of growth of the labeled primary afferent axons along the longitudinal axis of the spinal cord. Results showed both BDNF and fingolimod-p, an S1P1R agonist known to increase BDNF mRNA and protein production/secretion in cortical neurons, increased primary axon extension along the longitudinal pathway. Further, fingolimod-p increased BDNF mRNA production in DRG in this system. Conversely, inhibition of BDNF or S1PRs attenuated primary afferent axon extension along the longitudinal pathway. We found BDNF signaling to be required for fingolimod-p's effects as addition of αBDNF attenuated the effects of fingolimod-p on axon outgrowth. TrkB, the high affinity receptor for BDNF, is expressed in chicken DRG during embryonic development. We hypothesized that TrkB activation by BDNF regulates DRG axon extension in the longitudinal pathway through the PLC-γ signaling pathway. We found inhibition of TrkB and/or PLC-γ signaling pathway attenuated DRG axon extension with or without BDNF stimulation. Additional pathways associated with TrkB activation: mitogen activated kinase (MAPK) and phosphoinositide 3-kinase (PI3K) appeared to either have no effect on DRG axon extension or were involved in DRG axon extension through a mechanism that is not related to TrkB. Collectively, these studies suggest an endogenous mechanism for the regulation of DRG axon outgrowth within the longitudinal pathway. With this mechanism, DRG axon outgrowth may be enhanced or attenuated following manipulation of S1P1R, BDNF and/or TrkB. Further, these findings suggest an action through BDNF on CNS axons as a potential therapeutic effect of fingolimod-p, a treatment for relapsing remitting forms of Multiple Sclerosis
17

Kosteneffizienzanalyse der Polytrauma-Patienten im Jahr 2010 / Account analysis of multiple injured patients in 2010

Raida, Markus January 2014 (has links) (PDF)
Mit der Einführung des G-DRG Systems im Jahr 2003 änderte sich die Abrechnung der Behandlungskosten grundlegend. Die fallgenaue Berechnung der tatsächlich entstandenen Kosten wurde durch eine gleiche Vergütung gleicher Entlassdiagnosen ersetzt. Bereits vor Einführung des G-DRG wurde über mögliche negative Folgen insbesondere im Bereich der Schwerverletztenversorgung spekuliert. Besorgniserregende Studien aus anderen Ländern mit DRG-System sahen Traumazentren in der Gefahr einer ökonomiebedingten Schließung. Die ersten Veröffentlichungen nach Einführung des G-DRG bestätigten die zuvor getroffenen Befürchtungen und zeigten eine deutlich defizitäre Vergütung. Fallgenaue Berechnungen gibt es seither nur noch an den Kalkulationshäusern des InEK. Das UKW steht als überregionales Traumazentrum im Focus dieses Missstandes und gewährleistet indes die Versorgung von rund 120 Polytrauma-Patienten pro Jahr. Diese Studie betrachtet retrospektiv die tatsächlich entstandenen Kosten von 43 solcher Patienten aus dem Jahr 2010 mit einem mittleren ISS von 22,7±9,9 Punkten und benutzt dazu eigene Berechnungen. Die berechneten Kostenfaktoren sind OP-Kosten (Personal und Material), Radiologie, Labor, Transfusion, Anästhesie und Intensivstation. Diese beziehen sich auf tatsächlich entstandene Kosten. Infrastruktur und Vorhaltung finden dabei beispielsweise keine Beachtung. Es zeigt sich eine Kostenunterdeckung von 2.616±7.461€ pro Patient. Hauptsächlich wurden die MDCs Prä-MDC (Langzeitbeatmung) und MDC 08 (vom DRG nicht als Polytrauma erkannte Fälle) defizitär vergütet. Die wesentlichen Kostenanteile entfallen auf die Kosten der Intensivstation. Trotz der Nichtbeachtung relevanter Kostenpunkte, wie dem der Vorhaltekosten, konnte bereits eine Unterfinanzierung des Patientenkollektivs nachgewiesen werden. Die tatsächlichen Kosten scheinen in ihrer Gesamtsumme also noch deutlich höher zu liegen. Die bisherigen Anpassungen des Entgeltsystems durch Erhöhung des Basisfallwertes und der Abbildungsgenauigkeit scheinen unzureichend zu sein. Eine Forderung nach fallgenauer Berechnung insbesondere im Bereich klinischer Polytrauma-Patienten, die jedoch in eine andere MDC eingeordnet wurden, scheint gerechtfertigt. Gerade im Hinblick auf eine weitere Zentralisierung der Schwerverletztenversorgung im Zuge des Ausbaus des Traumanetzwerks der DGU und des Schwerstverletzungsartenverfahrens der DGUV. / Account analysis of multiple injured patients in 2010
18

Ekonomistyrning vid sjukhus med stöd av kostnad per patient

Proos, Julia, Gustafsson, Ulla Britt January 2009 (has links)
<p>Denna uppsats studerar universitetssjukhus implementering och användning av måttet KPP, kostnad per patient, inom den interna ekonomiska uppföljningen i somatisk slutenvård genom en intervju- och enkätundersökning.  Syftet är att se hur KPP bör implementeras och användas. Slutsatsen är att sjukhusens ledning inte fokuserats på den strategiska och operativa styrningen med hjälp av KPP, vilket försenat utbredningen av den interna användningen. KPP-måttet måste vara tillgängligt för alla nivåer inom sjukhuset och speciellt för verksamhetschefer med ansvar för vården av patienter; goda IT-system är också nödvändiga. Tiden sedan KPP införts har påverkat den interna användningen.</p>
19

Ekonomistyrning vid sjukhus med stöd av kostnad per patient

Proos, Julia, Gustafsson, Ulla Britt January 2009 (has links)
Denna uppsats studerar universitetssjukhus implementering och användning av måttet KPP, kostnad per patient, inom den interna ekonomiska uppföljningen i somatisk slutenvård genom en intervju- och enkätundersökning.  Syftet är att se hur KPP bör implementeras och användas. Slutsatsen är att sjukhusens ledning inte fokuserats på den strategiska och operativa styrningen med hjälp av KPP, vilket försenat utbredningen av den interna användningen. KPP-måttet måste vara tillgängligt för alla nivåer inom sjukhuset och speciellt för verksamhetschefer med ansvar för vården av patienter; goda IT-system är också nödvändiga. Tiden sedan KPP införts har påverkat den interna användningen.
20

Analysis of the Outlier in the Case Payment of Laparoscopic Cholecystectomy

Tung, Hong-Yi 07 February 2011 (has links)
Objectives: Study wanted to explore the factors that will affect the total medical expense in the patients who receive laparoscopic cholecystectomy (LC). We also to confer the influencing factor that will associate with the difference of reports the expense under the case payment system. Methods:Retrospective study . Collected from year 2003 to 2007, received LC in a general teaching hospital in Kaohsiung city. We also adopt the chart review and combined with the health insurance expense data to explore the important factors that were associated with total hospitalized expenses, declaration of expense differences, and profits. The methods of multiple linear and logistic regressions were needed. Results: 1539 subjects, 613 male and 926 female. The average age was 54.4 , and 1313 subjects were hospitalized from outpatient. All subject¡¦s average hospitalized days were 3.79 and medical expenses were 42528.1 dollars. The frequencies of the type of declaration about ¡¥not exceed¡¦, ¡¥exceed but actually¡¦, and ¡¥exceed but no actually¡¦ were 88.8%, 8.6%, and 2.6%, in sequence. The average declaration of expense differences was 14484.1 dollars. The significant factors that were associated with total hospitalized expenses were the age, surgical year, source of hospitalize, major symptom, combine disease, a complication after surgery, hospitalized days, type of declaration. In the other linear regression model, we found the age, surgery year, source of hospitalize, major symptom, high technology examination before surgery, combine disease, a complication after surgery, hospitalized days, and physician¡¦s surgery quantity per year had been statistically significant with the declaration of expense differences. For the odds of hospital¡¦s profits, the significant factors include the surgery year, source of hospitalize, major symptom, high technology examination before surgery, and hospitalized days. Conclusion: We found a few significant factors that were associated with dependent variable in three regression models in this study. The major factor is hospitalized days that were a stronger influence total hospitalized expenses, declaration of expense differences, and hospital¡¦s profits. The hospital¡¦s superintendent can carry on the management through the appropriate method to control the medical resource consumes.

Page generated in 0.0999 seconds